Stefan Laufer is professor for Pharmaceutical and Medicinal Chemistry at Tuebingen University. He received his degrees from Regensburg University. After 10 years in the pharmaceutical industry, he joined Tuebingen University as chairman Pharmaceutical/Medicinal Chemistry in 1999. His research interests are anti-inflammatory and auto-immune drug discovery against various eicosanoid and kinase targets. Three compounds from his lab entered clinical development phases. He chairs or co-chairs the ICEPHA (Interfaculty Center for Pharmacogenomics and Drug Research), an academic drug-discovery platform at Tuebingen University and Robert Bosch Hospital Stuttgart, and TuCADD (Tuebingen Center for Academic Drug Discovery). Dr. Laufer has authored more than 350 publications, 13 books or book chapters, and is an inventor in 40 patent families.